Literature DB >> 16302008

Hypertension, single sugars and fatty acids.

P Valensi1.   

Abstract

Macronutrients may induce various hemodynamic effects. In the fructose-fed rat blood pressure increase is associated with insulin resistance and enhanced sympathetic activity. In humans, oral glucose intake induces a slight and transient increase of blood pressure secondary to sympathetic activation. This increase may be higher in hypertensive subjects and followed by a significant fall in blood pressure in elderly subjects. Saturated fatty acid-enriched diet induces in male rats a significant increase in blood pressure related to sympathetic activation. Some observational and interventional studies suggest that n-3 polyunsaturated fatty-acids may reduce blood pressure in humans. Thus, both carbohydrates and fatty acid balance may contribute to blood pressure changes. The clinical relevance of these data should be evaluated in long-term trials, in particular in overweight and hypertensive subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302008     DOI: 10.1038/sj.jhh.1001954

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  12 in total

1.  Erythrocyte fatty acid composition is associated with the risk of hypertension in middle-aged and older women.

Authors:  Lu Wang; Michael Tsai; Joann E Manson; Luc Djousse; J Michael Gaziano; Julie E Buring; Howard D Sesso
Journal:  J Nutr       Date:  2011-07-06       Impact factor: 4.798

2.  Dietary fatty acids and the risk of hypertension in middle-aged and older women.

Authors:  Lu Wang; Joann E Manson; John P Forman; J Michael Gaziano; Julie E Buring; Howard D Sesso
Journal:  Hypertension       Date:  2010-08-16       Impact factor: 10.190

3.  Dietary patterns, nutrition knowledge and lifestyle: associations with blood pressure in a sample of Australian adults (the Food BP study).

Authors:  S Khalesi; S Sharma; C Irwin; J Sun
Journal:  J Hum Hypertens       Date:  2016-04-28       Impact factor: 3.012

4.  Healthful Dietary Patterns and the Risk of Hypertension Among Women With a History of Gestational Diabetes Mellitus: A Prospective Cohort Study.

Authors:  Shanshan Li; Yeyi Zhu; Jorge E Chavarro; Wei Bao; Deirdre K Tobias; Sylvia H Ley; John P Forman; Aiyi Liu; James Mills; Katherine Bowers; Marin Strøm; Susanne Hansen; Frank B Hu; Cuilin Zhang
Journal:  Hypertension       Date:  2016-04-18       Impact factor: 10.190

5.  Effect of moderate intake of sweeteners on metabolic health in the rat.

Authors:  D P Figlewicz; G Ioannou; J Bennett Jay; S Kittleson; C Savard; C L Roth
Journal:  Physiol Behav       Date:  2009-10-06

6.  The role of salt in the pathogenesis of fructose-induced hypertension.

Authors:  Manoocher Soleimani; Pooneh Alborzi
Journal:  Int J Nephrol       Date:  2011-07-18

7.  Effects of Virgin Olive Oil on Blood Pressure and Renal Aminopeptidase Activities in Male Wistar Rats.

Authors:  Germán Domínguez-Vías; Ana Belén Segarra; Manuel Ramírez-Sánchez; Isabel Prieto
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

8.  Phosphorus Supplementation Mitigates Perivascular Adipose Inflammation-Induced Cardiovascular Consequences in Early Metabolic Impairment.

Authors:  Haneen S Dwaib; Ghina Ajouz; Ibrahim AlZaim; Rim Rafeh; Ali Mroueh; Nahed Mougharbil; Marie-Elizabeth Ragi; Marwan Refaat; Omar Obeid; Ahmed F El-Yazbi
Journal:  J Am Heart Assoc       Date:  2021-12-07       Impact factor: 6.106

9.  Aronia melanocarpa treatment and antioxidant status in selected tissues in Wistar rats.

Authors:  Renata Francik; Mirosław Krośniak; Ilona Sanocka; Henryk Bartoń; Tomasz Hebda; Sławomir Francik
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

10.  Cardiac Autonomic Neuropathy as a Result of Mild Hypercaloric Challenge in Absence of Signs of Diabetes: Modulation by Antidiabetic Drugs.

Authors:  Ola Al-Assi; Rana Ghali; Ali Mroueh; Abdullah Kaplan; Nahed Mougharbil; Ali H Eid; Fouad A Zouein; Ahmed F El-Yazbi
Journal:  Oxid Med Cell Longev       Date:  2018-01-31       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.